Upper extremity deep venous thrombosis: An underrecognized manifestation of a hypercoagulable state

被引:14
作者
Hingorani, A [1 ]
Ascher, E [1 ]
Yorkavich, W [1 ]
Mazzariol, F [1 ]
Jacob, T [1 ]
Gunduz, Y [1 ]
Salles-Cunha, S [1 ]
机构
[1] Maimonides Hosp, Div Vasc Surg, Dept Surg, Brooklyn, NY 11219 USA
关键词
D O I
10.1007/s100169910084
中图分类号
R61 [外科手术学];
学科分类号
摘要
Although lower extremity deep venous thrombosis (LEDVT) has been associated with a hypercoagulable state, there are scant data available for patients presenting with upper extremity deep venous thrombosis (UEDVT). Therefore, we conducted a prospective study to determine whether such an association exists for UEDVT. Fifty-two patients who presented with UEDVT at our institution from August 1996 to June 1997 underwent a hematological profile consisting of activated protein C (APC) resistance, antithrombin III (ATIII) level and activity, factor V mutation (arginine 506 to glycine), protein C level and activity, protein S level and activity, factors II and X activity, lupus anticoagulant, and cardiolipin antibody. This represented 68% (52/76) of the total number of patients in whom the diagnosis of UEDVT was made by duplex ultrasonography during this time period. The ages ranged from 9 to 97 (mean 63 +/- 23 years). There were 22 males and 30 females. Twenty-five patients (48%) had a central venous line in place, 4 patients (48%) had a pacemaker, 14 patients (27%) had a history of neoplasm, and 7 patients (13%) had concomitant LEDVT. The results of our study showed that a hypercoagulable state may be an underappreciated contributing factor in the development of UEDVT. Contrary to prior belief that three sets of tests are needed to confirm the presence of a hypercoagulable state, these data also suggest that only two tests may be needed. DOI: 10.1007/s100169910084.
引用
收藏
页码:421 / 426
页数:6
相关论文
共 39 条
[1]  
BENNET JS, 1995, TXB INTERNAL MED, P1426
[2]  
BERQUIST D, 1983, POSTOPERATIVE THROMB
[3]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[4]  
BOWEN KJ, 1992, POSTGRAD MED, V91, P117
[5]   A NEW METHOD FOR THE ESTIMATION OF PROTEIN-C BY ELISA [J].
BOYER, C ;
ROTHSCHILD, C ;
WOLF, M ;
AMIRAL, J ;
MEYER, D ;
LARRIEU, MJ .
THROMBOSIS RESEARCH, 1984, 36 (06) :579-589
[6]   ANTICARDIOLIPIN ANTIBODIES ASSOCIATED WITH HTLV-III INFECTION [J].
CANOSO, RT ;
ZON, LI ;
GROOPMAN, JE .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (04) :495-498
[7]  
COMP PC, 1986, BLOOD, V67, P504
[8]   VENOUS THROMBOEMBOLIC DISEASE - THE ROLE OF US [J].
CRONAN, JJ .
RADIOLOGY, 1993, 186 (03) :619-630
[9]   CONTEMPORARY VENOUS IMAGING [J].
CRONAN, JJ .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1991, 14 (02) :87-97
[10]   FAMILIAL THROMBOPHILIA DUE TO A PREVIOUSLY UNRECOGNIZED MECHANISM CHARACTERIZED BY POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - PREDICTION OF A COFACTOR TO ACTIVATED PROTEIN-C [J].
DAHLBACK, B ;
CARLSSON, M ;
SVENSSON, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1004-1008